Role of γδ T lymphocytes in the development of Behc¸et's disease

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical and Experimental Immunology

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2249.1997.274-ce1159.xPMID 9030859PMCID PMC1904583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular cloning and chromosomal assignment of a human perforin (PFP) gene

  2006cited by this paper
• Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice.

  1995cited by this paper
• Multiple self epitopes on the Rhesus polypeptides stimulate immunologically ignorant human T cells in vitro

  1994cited by this paper
• The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice.

  1994cited by this paper
• IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells.

  1994cited by this paper
• T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.

  1993cited by this paper
• Selective activation of resting human γδ T lymphocytes by interleukin‐2

  1993cited by this paper
• Selective activation of resting human gamma delta T lymphocytes by interleukin-2.

  1993cited by this paper
• Constitutive expression and production of tumor necrosis factor-beta in T-cell lines infected with HTLV-I and HTLV-II.

  1993cited by this paper
• Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen.

  1993cited by this paper
• Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response.

  1992cited by this paper
• Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.

  1992cited by this paper
• Gamma delta T cells assist alpha beta T cells in adoptive transfer of contact sensitivity.

  1992cited by this paper
• CD4+ lymphocyte involvement in ocular Behçet's disease.

  1992cited by this paper
• Cyclic regulation of CD45 isoform expression in a long term human CD4+CD45RA+ T cell line.

  1991cited by this paper
• High gradient magnetic cell separation with MACS.

  1990cited by this paper
• Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire

  1990cited by this paper
• Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo

  1990cited by this paper
• The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome.

  1990cited by this paper
• Differential expression of CD45RO (UCHL1) and its functional relevance in two subpopulations of circulating TCR-gamma/delta+ lymphocytes

  1990cited by this paper
• Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis.

  1989cited by this paper
• Phenotypic characterization of the post-thymic differentiation of human alloantigen-specific CD8+ cytotoxic T lymphocytes.

  1989cited by this paper
• Intestinal intraepithelial lymphocytes are a distinct set of gamma delta T cells.

  1988cited by this paper
• Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test.

  1988cited by this paper
• Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

  1988cited by this paper
• Frontiers of the immune system

  1988cited by this paper
• The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation.

  1988cited by this paper
• Analysis of interleukin-2 activity in patients with Behçet's disease. Ability of T cells to produce and respond to interleukin-2.

  1986cited by this paper
• Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.

  1982cited by this paper
• Functional aberration of T cell subsets in patients with Behçet's disease.

  1982cited by this paper
• Behçet disease (Behçet syndrome).

  1979cited by this paper
• Cellular augmentation of polymorphonuclear leukocyte chemotaxis.

  1979cited by this paper
• [Criteria of diagnosis of Behcet's disease].

  1975cited by this paper
• Leucocyte movement and colchicine treatment in Behcet's disease.

  1975cited by this paper
• Pathology of recurrent oral ulceration and oral ulceration in behcet's syndrome: Light, electron and fluorescence microscopy

  1969cited by this paper

• γδ T cells in autoimmune uveitis pathogenesis: a promising therapeutic target.

  2023cites this paper
• Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

  2022cites this paper
• Low density neutrophils are increased in patients with Behçet’s disease but do not explain differences in neutrophil function

  2022cites this paper
• Immunopathology of Behcet’s Disease: An Overview of the Metagenomic Approaches

  2022cites this paper
• IL-17A and IFN-γ are Up-regulated in CD4 and γδ T Cells in Active Behcet's Disease Patients.

  2021cites this paper
• Ocular Involvement in Behcet’s Disease: An Overview

  2020cites this paper
• Effectiveness of tocilizumab for Behcet disease complicated by amyloidosis in the intestinal tract

  2020cites this paper
• The Genetic Aspects of Behçet’s Disease: Role of Cytokine Genes Polymorphisms

  2019cites this paper
• Acute neuro-Behçet’s disease with longitudinal extensive transverse myelitis in a patient receiving long-term anti-TNF-α therapy

  2019cites this paper
• Characteristics of intestinal Behçet's Disease and the comparison of different medications

  2019cites this paper
• Behçet’s disease: An immunogenetic perspective

  2018cites this paper
• An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review

  2017cites this paper
• Epigenetic alterations in chronic disease focusing on Behçet's disease: Review.

  2017cites this paper
• Initial ferritin level, g/L† TIL before chelation, mg/kg‡ TIL during chelation, mg/kg‡ UIE after DFO bolus, g/48 h UIE after DFO infusion, g/48 h Follow-up time, mo Last ferritin

  2017cites this paper
• A meta-analysis of the association between Behçet's disease and MICA-A6.

  2016cites this paper
• Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature.

  2016cites this paper
• Recurrent onycholysis in a patient with Behcet's disease

  2016cites this paper
• Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet’s Disease: Eight Consecutive Cases

  2016cites this paper
• Behçet syndrome: from pathogenesis to novel therapies

  2016cites this paper
• Adalimumab in the management of Behçet’s disease

  2015cites this paper
• Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease

  2015influential citation
• Inflammation-related cytokine gene polymorphisms in Behçet’s disease

  2015cites this paper
• The Immunopathology of Behçet’s Disease

  2015cites this paper
• Quantitative Peripheral Blood Perturbations of γδ T Cells in Human Disease and Their Clinical Implications

  2014cites this paper
• Etanercept therapy in Behçet’s disease

  2014cites this paper
• Etanercept therapy in Behçet’s disease

  2013cites this paper
• Outcome Predictors for Intestinal Behçet's Disease

  2013cites this paper
• Efficacy of Infliximab in Intestinal Behçet’s Disease: A Korean Multicenter Retrospective Study

  2013cites this paper
• Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet’s disease: An updated meta-analysis

  2013cites this paper
• Nachweis von IFN-γin Granulozyten bei Morbus

  2013cites this paper
• Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis).

  2013cites this paper
• Case of neuro‐Behçet's disease successfully maintained a remission using infliximab for 2 years

  2013cites this paper
• Behçet’s disease and genes within the major histocompatibility complex region

  2012cites this paper
• Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet's Disease

  2012cites this paper
• Switching of anti-TNF-α agents in Behçet's disease.

  2012cites this paper
• CAPÍTULO 7 – Anti-TNF-α y enfermedad de Behçet ocular

  2012cites this paper
• ВОЗМОЖНОСТИ ПРОТОЧНОЙ ЦИТОФЛЮОРИМЕТРИИ В ДИАГНОСТИКЕ ИНФЕКЦИОННЫХ ЗАБОЛЕВАНИЙ. Часть 2

  2011cites this paper
• [Infliximab treatment trial in a patient with neuro-Behçet's disease unresponsive to other treatments].

  2011cites this paper
• severe/refractory intestinal Behcet disease Autologous hematopoietic stem cell transplantation for

  2011cites this paper
• The Role of Biological Therapies in the Management of Systemic Vasculitis

  2011cites this paper
• Anti-tumor necrosis factor monoclonal antibody therapy for intestinal Behçet disease in an adolescent.

  2011cites this paper
• Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease

  2011cites this paper
• Clinical Experience with Adalimumab in the Treatment of Ocular Behçet Disease

  2010cites this paper
• Associations between TBX21 Gene Polymorphisms and Korean Patients with Behçet's Disease

  2010influential citation
• gammadelta T-cells: basic features and potential role in vasculitis.

  2010cites this paper
• Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.

  2010cites this paper
• Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

  2010cites this paper
• Analyses of functional IL10 and TNF-α genotypes in Behçet’s syndrome

  2010cites this paper
• Ocular involvement is associated with HLA-B51 in Adamantiades–Behçet's disease

  2009cites this paper
• Enfermedad de Behcet

  2009cites this paper
• Successful use of infliximab in a patient with neuro‐Behçet’s disease

  2009cites this paper
• The Role of Molecular Chaperones (Hspas/Hsp70S) in Oral Health and Oral Inflammatory Diseases: A Review

  2009cites this paper
• Effects of 15-Deoxy-Δ12,14-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human Vδ2+ T Cells

  2009cites this paper
• Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.

  2008cites this paper
• Serum adenosine deaminase levels in diagnosis of acute appendicitis

  2008cites this paper
• Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?

  2008cites this paper
• МНОГОЦВЕТНЫЙ ИЧЕСКИЙ АНАЛИЗ. ИДЕНТИФИКАЦИЯ Т-КЛЕТОК И ИХ СУБПОПУЛЯЦИЙ ПО ЭКСПРЕССИИ αβ-ТCR И γδ-ТCR

  2008cites this paper
• Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.

  2008cites this paper
• Adamantiades–Behçet's Disease

  2008cites this paper
• Preferential activation of circulating CD8+ and γδ T cells in patients with active Behçet's disease and HLA-B51

  2008cites this paper
• Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

  2008cites this paper
• Pro-inflammatory cellular immune response in Behçet’s disease

  2007cites this paper
• Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.

  2007cites this paper
• Major House Dust Mite Allergens Dermatophagoides pteronyssinus 1 and Dermatophagoides farinae 1 Degrade and Inactivate Lung Surfactant Proteins A and D*

  2007cites this paper
• Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)

  2007cites this paper
• Infliximab treatment-induced formation of autoantibodies is common in Behçet's disease.

  2007cites this paper
• Serum Adenosine Deaminase Levels in Pancreatic Diseases

  2007cites this paper
• Paradoxical high regulatory T cell activity in Behçet's disease.

  2007cites this paper
• Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.

  2007cites this paper
• Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.

  2007cites this paper
• Chapter 14 Behçet's Disease

  2007cites this paper
• Polymorphisms of TNF-α Gene and TNF Receptor Gene in Behcet's Disease

  2007cites this paper
• Association of TNFA Promoter Region Haplotype in Behçet's Disease

  2006cites this paper
• Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet’s disease

  2006cites this paper
• New approaches in the treatment of Adamantiades-Behçet's disease

  2006cites this paper
• Surfactant protein D in atopic dermatitis and psoriasis

  2006cites this paper
• Surfactant protein D inhibits early airway response in Aspergillus fumigatus‐sensitized mice

  2006cites this paper
• Surfactant protein D regulates chemotaxis and degranulation of human eosinophils

  2006cites this paper
• Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.

  2006cites this paper
• Surfactant protein D in human lung diseases

  2006cites this paper
• Ocular Manifestations in Behçet's Disease

  2006cites this paper
• Efficacy of TNF α blockade in cyclophosphamide resistant neuro-Behçet disease

  2005cites this paper
• Successful treatment of long-standing neuro-Behçet's disease with infliximab.

  2005cites this paper
• Homing and memory patterns of human γδ T cells in physiopathological situations

  2005cites this paper
• Homing and memory patterns of human gammadelta T cells in physiopathological situations.

  2005cites this paper
• Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease.

  2005cites this paper
• Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet’s disease

  2005cites this paper
• Therapeutic effect of surfactant protein D in allergic inflammation of mite‐sensitized mice

  2005cites this paper
• Current concepts in the etiology and treatment of Behçet disease.

  2005cites this paper
• Psoriasis Associated with Behçet's Disease

  2005cites this paper
• Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease.

  2004cites this paper
• Behcet’s disease

  2004cites this paper
• Serum Levels of Soluble TNF-α Receptor-II (P75), Circulating γδ T-Cells and Adamantiades-behçet’s Disease Activity

  2004cites this paper
• Influence of human recombinant interferon-α2a (rhIFN-α2a) on altered lymphocyte subpopulations and monocytes in Behçet's disease

  2004cites this paper
• Neutrophilic phlebitis is characteristic of intestinal Behçet's disease and simple ulcer syndrome

  2004cites this paper
• The level of soluble Granzyme A is elevated in the plasma and in the Vgamma9/Vdelta2 T cell culture supernatants of patients with active Behçet's disease.

  2004cites this paper
• Surfactant protein D deficiency influences allergic immune responses

  2004cites this paper
• Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.

  2004cites this paper
• Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.

  2003cites this paper
• Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

  2003cites this paper